OXOLIFE is celebrating. The European Commission has awarded us with the “Seal of Excellence” for our project “FIRST-IN CLASS DRUG TO ENHANCE FEMALE EMBRYO IMPLANTATION” submitted under the Horizon 2020’s SME Instrument.
A great encouragement for all the team that a panel of independent international experts value our project as innovative, trustful and with a clear outline for achieving our goals.
Thanks ARISTOS Innovation Consulting for being part of this.
#growwithus